|
Obagi Medical Products, Inc. - Comparative Business Analysis Snapshot
Business Description
Obagi Medical Products, Inc.. The Group's principal activity is to develop and market prescription-based, topical skin health systems in the aesthetic and therapeutic skin health markets. It helps physicians to treat a range of skin conditions, including pre-mature aging, photo-damage, hyper pigmentation, acne and soft tissue deficits, such as fine lines and wrinkles. Its product lines are prescription-based skin health systems that improve the efficacy of established prescription and over-the-counter, therapeutic agents by enhancing the penetration of these agents across the skin barrier using proprietary technologies. It also licenses certain non-prescription product concepts under the Obagi trademark to a large Japanese based Pharmaceutical company. The Group introduced ELASTIdermTM product line, ELASTIdermTM Eye Cream, a for treatment of skin laxity around the eye.
Competitor Analysis
This analysis compares Obagi Medical Products, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
